A novel in vivo regulatory role of P-glycoprotein in alloimmunity

Biochemical and Biophysical Research Communications

Volumn 394, Issue 3, 2010, Pages 646-652

  Izawa, Atsushi ^a   Schatton, Tobias ^a   Frank, Natasha Y ^b,c   Ueno, Takuya ^a   Yamaura, Kazuhiro ^a   Pendse, Shona S ^a   Margaryan, Armen ^a   Grimm, Martin ^d   Gasser, Martin ^d   Waaga Gasser, Ana Maria ^d   Sayegh, Mohamed H ^a   Frank, Markus H ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antigen presenting cell; CD86; Immunity; P glycoprotein; T cell; Transplantation

Indexed keywords

B7 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; GLYCOPROTEIN P; INTERLEUKIN 4; RHODAMINE 123; VALSPODAR;

ADAPTIVE IMMUNITY; ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CARDIAC GRAFT REJECTION; CELL DEATH; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOREGULATION; IN VIVO STUDY; INTERFERON PRODUCTION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; GENE KNOCKOUT TECHNIQUES; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; P-GLYCOPROTEIN; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

MURINAE;

EID: 77950518403     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.040     Document Type: Article

References (22)

1. Raymond M., Rose E., Housman D.E., and Gros P. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol. Cell. Biol. 10 (1990) 1642-1651
2. Drach D., Zhao S., Drach J., Mahadevia R., Gattringer C., Huber H., and Andreeff M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80 (1992) 2729-2734
3. Klimecki W.T., Futscher B.W., Grogan T.M., and Dalton W.S. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83 (1994) 2451-2458
4. Frank M.H., Denton M.D., Alexander S.I., Khoury S.J., Sayegh M.H., and Briscoe D.M. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J. Immunol. 166 (2001) 2451-2459
5. + T cells: a role in cytotoxic effector function. J. Clin. Immunol. 12 (1992) 451-458
6. Drach J., Gsur A., Hamilton G., Zhao S., Angerler J., Fiegl M., Zojer N., Raderer M., Haberl I., Andreeff M., and Huber H. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 88 (1996) 1747-1754
7. Raghu G., Park S.W., Roninson I.B., and Mechetner E.B. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp. Hematol. 24 (1996) 1258-1264
8. Kobayashi Y., Yamashiro T., Nagatake H., Yamamoto T., Watanabe N., Tanaka H., Shigenobu K., and Tsuruo T. Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52. Biochem. Pharmacol. 48 (1994) 1641-1646
9. Klimecki W.T., Taylor C.W., and Dalton W.S. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs. J. Clin. Immunol. 15 (1995) 152-158
10. Randolph G.J., Beaulieu S., Lebecque S., Steinman R.M., and Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282 (1998) 480-483
11. Pendse S.S., Behjati S., Schatton T., Izawa A., Sayegh M.H., and Frank M.H. P-glycoprotein functions as a differentiation switch in antigen presenting cell maturation. Am. J. Transplant. 6 (2006) 2884-2893
12. Kooij G., Backer R., Koning J.J., Reijerkerk A., van Horssen J., van der Pol S.M., Drexhage J., Schinkel A., Dijkstra C.D., den Haan J.M., Geijtenbeek T.B., and de Vries H.E. P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One 4 (2009) e8212
13. Pendse S., Sayegh M.H., and Frank M.H. P-glycoprotein - a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity?. Curr. Drug Targets 4 (2003) 469-476
14. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L., Smit J.J., van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M., Fibbe W.E., and Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94 (1997) 4028-4033
15. Frank N.Y., Margaryan A., Huang Y., Schatton T., Waaga-Gasser A.M., Gasser M., Sayegh M.H., Sadee W., and Frank M.H. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 65 (2005) 4320-4333
16. Frank N.Y., Pendse S.S., Lapchak P.H., Margaryan A., Shlain D., Doeing C., Sayegh M.H., and Frank M.H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 278 (2003) 47156-47165
17. Schatton T., Schutte U., Frank N.Y., Zhan Q., Hoerning A., Robles S.C., Zhou J., Hodi F.S., Spagnoli G.C., Murphy G.F., and Frank M.H. Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res. 70 (2010) 697-708
18. Yamada A., Kishimoto K., Dong V.M., Sho M., Salama A.D., Anosova N.G., Benichou G., Mandelbrot D.A., Sharpe A.H., Turka L.A., Auchincloss Jr. H., and Sayegh M.H. CD28-independent costimulation of T cells in alloimmune responses. J. Immunol. 167 (2001) 140-146
19. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., Fuhlbrigge R.C., Kupper T.S., Sayegh M.H., and Frank M.H. Identification of cells initiating human melanomas. Nature 451 (2008) 345-349
20. Eisenbraun M.D., and Miller R.A. mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice. J. Immunol. 163 (1999) 2621-2627
21. Sayegh M.H., Akalin E., Hancock W.W., Russell M.E., Carpenter C.B., Linsley P.S., and Turka L.A. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181 (1995) 1869-1874
22. Wang H., Hosiawa K.A., Min W., Yang J., Zhang X., Garcia B., Ichim T.E., Zhou D., Lian D., Kelvin D.J., and Zhong R. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J. Immunol. 171 (2003) 3823-3836